Skip to main content
Figure 1 | BMC Medical Genomics

Figure 1

From: A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone

Figure 1

Effect of drug treatment on metabolic parameters in LDLr-/- mice fed a chow diet or an HF-diet supplemented with rosiglitazone (HF + Rosi) or pioglitazone (HF + Pio). Fasting plasma levels of glucose (A) and insulin (B), and albumin/creatinin ratio in urine (C). Values are mean ± SD. # indicates statistical significance P < 0.05 compared to chow, *indicates statistical significance P < 0.05 compared to HF-diet.

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us